BeStock  
Markets › Compare › IMCR vs NRIX

IMCR vs NRIX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
IMCR · Immunocore$26.41 ▼ 0.83%
NRIX · Nurix Therapeutics$12.85 ▼ 5.51%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

6389115141168Nov 24, '25May 26, '26Nov 20, '26
  • IMCR -31.7%
  • NRIX -25.1%

Head to head

MetricIMCRNRIX
Price$26.41$12.85
Change today▼ 0.83%▼ 5.51%
Market cap$1.36B$1.40B
Return, 3 months-27.9%-51.1%
Return, year to date-23.9%-32.3%
Return, 1 year-32.9%-23.3%
P/E (TTM)–5.3
P/B3.31.4
P/E percentile vs own 5y44th98th
Dividend yield––
Revenue growth (YoY, latest qtr)-1.4%+8,426.3%
Net profit growth (YoY)-7,935.0%+736.2%
Gross margin98.9%–
Operating margin-6.8%41.3%
Net margin-7.5%42.0%
Return on equity-7.9%44.0%
Analyst target vs. price+115.1%+174.9%
Analyst buy share60%100%
RSI (14)3321
30-day volatility53.9%149.6%
Max drawdown, 1 year-34.3%-53.8%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • NRIX is the largest of the group by market value.
  • NRIX has returned the most over the past year.
  • NRIX is growing revenue fastest.
  • NRIX keeps the most profit per dollar of sales.
  • IMCR has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top